Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that it protects older people most at risk of dying from COVID.
Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that it protects older people most at risk of dying from COVID.